Bait Bakfar Ltd (TLV:BKFR)
1,386.00
-2.00 (-0.14%)
Sep 2, 2026, 5:24 PM IDT
Bait Bakfar Revenue
Bait Bakfar had revenue of 31.17M ILS in the quarter ending June 30, 2026, with 14.15% growth. This brings the company's revenue in the last twelve months to 115.76M, up 8.96% year-over-year. In the year 2025, Bait Bakfar had annual revenue of 109.62M with 6.02% growth.
Revenue (ttm)
115.76M
Revenue Growth
+8.96%
P/S Ratio
8.37
Revenue / Employee
474.44K
Employees
244
Market Cap
969.28M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.62M | 6.23M | 6.02% |
| Dec 31, 2024 | 103.40M | 4.30M | 4.34% |
| Dec 31, 2023 | 99.10M | 6.11M | 6.58% |
| Dec 31, 2022 | 92.99M | 7.60M | 8.90% |
| Dec 31, 2021 | 85.39M | 944.00K | 1.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 51.58B |
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.18B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 885.35M |
| Kamada | 571.54M |
| SofWave Medical | 310.85M |
| InterCure | 270.20M |